| Literature DB >> 35910826 |
Mitra Kar1, Akanksha Dubey1, Sangram Singh Patel1, Tasneem Siddiqui1, Ujjala Ghoshal1, Chinmoy Sahu2.
Abstract
Introduction: Infections associated with catheter in the upper urinary tract (CUUT), which include the double-J stent and the percutaneous nephrostomy (PCN) tube, get particularly infected in patients with specific risk factors for developing an infection.Entities:
Keywords: Bacteria; colonization; double-j stent; nephrostomy tube; urinary tract infection
Year: 2022 PMID: 35910826 PMCID: PMC9336602 DOI: 10.4103/jgid.jgid_276_21
Source DB: PubMed Journal: J Glob Infect Dis ISSN: 0974-777X
Descriptive analysis of demographic characteristics and risk factors in patients with a catheter in the upper urinary tract (n=200)
| Demographic characteristics and risk factors | Double-J Stent ( | Nephrostomy ( |
|
|---|---|---|---|
| Source of infection | |||
| Community-acquired | 13 (13.54) | 15 (14.42) | 0.858 |
| Nosocomially acquired | 40 (41.66) | 43 (41.34) | 0.963 |
| Cause for placement of the CUUT | |||
| Lithiasis | 55 (57.29) | 51 (49.03) | 0.243 |
| Tumor/other cause | 41 (42.71) | 27 (25.96) | 0.617 |
| Demographics | |||
| Age (years), mean (SD) | 40.49 (16.43) | 41.73 (19.49) | 0.628 |
| Gender (male/female) | 68.75/31.25 | 64.42/35.58 | 0.517 |
| ASA score | |||
| ASA I-II | 53 (55.20) | 52 (49.05) | 0.599 |
| ASA III-IV | 43 (44.80) | 52 (49.05) | |
| Comorbidities | |||
| Hypertension | 47 (48.95) | 49 (46.22) | 0.794 |
| Diabetes mellitus | 25 (26.04) | 29 (27.35) | 0.769 |
| Heart disease | 18 (18.75) | 21 (19.81) | 0.797 |
| Liver disease | 2 (2.08) | 4 (3.77) | 0.465 |
| Immunosupression | 15 (15.625) | 18 (17.3) | 0.749 |
| Urology history | |||
| Prior urinary infection | 29 (30.20) | 32 (30.18) | 0.931 |
| Urinary catheter before admission | 51 (53.12) | 46 (43.39) | 0.209 |
| Time with the catheter (days), mean (SD) | 67.60 (25.12) | 64.46 (22.82) | 0.355 |
| Hospitalization period (days), mean (SD) | 12.65 (6.79) | 12.01 (6.56) | 0.498 |
P<0.05 is significant. CUUT: Catheter in the upper urinary tract, ASA: American Society of Anesthesiologists [20], SD: Standard deviation
Figure 1Microorganisms isolated from patients with double-j stent and nephrostomy tube (N = 107). PCN: Percutaneous nephrostomy
Risk factors for isolation of multiple-drug resistance microorganisms in patients with a catheter in the upper urinary tract (n=75)
| Demographic characters and risk factors | Incidence of MDR microorganisms ( |
| 95% CI |
|---|---|---|---|
| Source of infection | |||
| Community-acquired | 16 (21.33) | 0.021* | 0.010-0.060 |
| Nosocomially acquired | 59 (78.76) | <0.001* | 0.000-0.015 |
| Cause for placement of the CUUT | |||
| Lithiasis | 35 (46.67) | 0.165 | 0.154-0.266 |
| Tumor/other cause | 40 (53.33) | 0.899 | 0.988-1.014 |
| Demographics | |||
| Age (years), mean (SD) | 38.95 (17.16) | 0.250 | 0.695-0.815 |
| Gender (male/female) | 66.67/33.33 | 0.969 | 0.986-1.023 |
| ASA score | |||
| ASA I-II | 35 (46.67) | 0.584 | 0.532-0.668 |
| ASA III-IV | 40 (53.33) | ||
| Comorbidities | |||
| Hypertension | 34 (45.33) | 0.559 | 0.594-0.726 |
| Diabetes mellitus | 20 (26.67) | 0.934 | 0.99-1.33 |
| Heart disease | 14 (18.67) | 0.818 | 0.818-0.912 |
| Liver disease | 3 (4.00) | 0.521 | 0.584-0.716 |
| Immunosupression | 17 (22.67) | 0.069 | 0.050-0.130 |
| Urology history | |||
| Prior urinary infection | 31 (41.33) | 0.010* | 0.000-0.024 |
| Urinary catheter before admission | 46 (61.33) | 0.005* | 0.000-0.015 |
| Time with the catheter (days), mean (SD) | 54.25 (19.46) | <0.001* | 0.000-0.023 |
| Hospitalization period (days), mean (SD) | 11.24 (6.47) | 0.036* | 0.114-0.216 |
*P<0.05 is significant. MDR microorganisms include extended spectrum beta - Lactamase-producing enterobacteriacae, carbapenemase-producing microorganism, Pseudomonas resistant to at least 3 group of antibiotics, Methicillin-resistant Staphylococcous and Vancomycin-resistant Enterococcous species. CUUT: Catheter in the upper urinary tract, ASA: American Society of Anesthesiologists, SD: Standard deviation, MDR: Multiple-drug resistance, CI: Confidence interval